128 related articles for article (PubMed ID: 20010472)
1. Peritoneal dialysis as a therapeutic approach in congestive heart failure resistant to pharmacological treatment: case report.
Próchnicka A; Olszowska A; Baczyński D; Zelichowski G; Lubas A; Wiśniewska M; Dziekiewicz M; Wańkowicz Z
Pol Arch Med Wewn; 2009 Dec; 119(12):834-7. PubMed ID: 20010472
[TBL] [Abstract][Full Text] [Related]
2. Diuretic-resistant congestive heart failure treated successfully with peritoneal ultrafiltration.
Próchnicka A; Krzesiński P; Hałas K; Dziuk M; Niemczyk S; Wańkowicz Z
Kardiol Pol; 2013; 71(4):393-5. PubMed ID: 23788345
[TBL] [Abstract][Full Text] [Related]
3. Peritoneal dialysis as a therapeutic approach in congestive heart failure resistant to pharmacological treatment.
Próchnicka A; Olszowska A; Baczyński D; Zelichowski G; Wańkowicz Z
Pol Arch Med Wewn; 2009 Dec; 119(12):815-9. PubMed ID: 20010468
[TBL] [Abstract][Full Text] [Related]
4. Patients initiating peritoneal dialysis started on two icodextrin exchanges daily.
Awuah KT; Gorban-Brennan N; Yalamanchili HB; Finkelstein FO
Adv Perit Dial; 2013; 29():1-3. PubMed ID: 24344481
[TBL] [Abstract][Full Text] [Related]
5. When should icodextrin be started to improve atherosclerosis in peritoneal dialysis patients?
Hiramatsu T; Hayasaki T; Hobo A; Furuta S; Kabu K; Tonozuka Y; Iida Y
Adv Perit Dial; 2013; 29():4-8. PubMed ID: 24344482
[TBL] [Abstract][Full Text] [Related]
6. Two daytime icodextrin exchanges decrease brain natriuretic peptide levels and improve cardiac functions in continuous ambulatory peritoneal dialysis patients.
Sav T; Inanc MT; Dogan A; Oymak O; Utas C
Nephrology (Carlton); 2010 Apr; 15(3):307-12. PubMed ID: 20470299
[TBL] [Abstract][Full Text] [Related]
7. Effects of twice-daily icodextrin administration on blood pressure and left ventricular mass in patients on continuous ambulatory peritoneal dialysis.
Sav T; Oymak O; Inanc MT; Dogan A; Tokgoz B; Utas C
Perit Dial Int; 2009; 29(4):443-9. PubMed ID: 19602610
[TBL] [Abstract][Full Text] [Related]
8. "Icodextrin alone" for initiation of peritoneal dialysis.
Jeloka TK
Perit Dial Int; 2008; 28(5):563-4. PubMed ID: 18708559
[No Abstract] [Full Text] [Related]
9. Icodextrin and peritoneal dialysis: advantages and new applications.
Dousdampanis P; Musso CG; Trigka K
Int Urol Nephrol; 2018 Mar; 50(3):495-500. PubMed ID: 28674854
[TBL] [Abstract][Full Text] [Related]
10. [Is intermittent peritoneal dialysis with icodextrin a valid option in the long-term treatment of refractory congestive heart failure?].
Basile C; Chimienti D; Bruno A; Cocola S; Libutti P; Teutonico A; Cazzato F
G Ital Nefrol; 2009; 26 Suppl 46():44-9. PubMed ID: 19644817
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of peritoneal dialysis with icodextrin in the long-term treatment of refractory congestive heart failure.
Basile C; Chimienti D; Bruno A; Cocola S; Libutti P; Teutonico A; Cazzato F
Perit Dial Int; 2009; 29(1):116-8. PubMed ID: 19164263
[No Abstract] [Full Text] [Related]
12. The kinetics of water transperitoneal transport during long-term peritoneal dialysis performed using icodextrin dialysis fluid.
Olszowska A; Zelichowski G; Waniewski J; Stachowska-Pietka J; Weryński A; Wańkowicz Z
Pol Arch Med Wewn; 2009 May; 119(5):305-10. PubMed ID: 19579812
[TBL] [Abstract][Full Text] [Related]
13. The utility of two daytime icodextrin exchanges to reduce dextrose exposure in automated peritoneal dialysis patients: a pilot study of nine patients.
Gobin J; Fernando S; Santacroce S; Finkelstein FO
Blood Purif; 2008; 26(3):279-83. PubMed ID: 18421212
[TBL] [Abstract][Full Text] [Related]
14. Successful use of icodextrin in elderly patients on continuous ambulatory peritoneal dialysis.
Nakamoto H; Babazono T; Kasai K; Kuriyama S; Sugimoto T; Nakayama M; Hamada C; Furuya R; Hasegawa H; Kasahara M; Moriishi M; Tomo T; Miyazaki M; Yorioka N; Sato M; Yamabe K; Kawaguchi Y
Adv Perit Dial; 2005; 21():168-74. PubMed ID: 16686312
[TBL] [Abstract][Full Text] [Related]
15. Clinical effects of a peritoneal dialysis regimen low in glucose in new peritoneal dialysis patients: a randomized crossover study.
le Poole CY; van Ittersum FJ; Weijmer MC; Valentijn RM; ter Wee PM
Adv Perit Dial; 2004; 20():170-6. PubMed ID: 15384821
[TBL] [Abstract][Full Text] [Related]
16. Volume control in peritoneal dialysis patients: role of new dialysis solutions.
Lameire N
Blood Purif; 2004; 22(1):44-54. PubMed ID: 14732811
[TBL] [Abstract][Full Text] [Related]
17. [New peritoneal dialysis solutions and their combinations].
Bajo MA; del Peso G; Sánchez-Villanueva R; Castro MJ; Aroeira L; Selgas R
Nefrologia; 2008; 28 Suppl 6():59-66. PubMed ID: 18957014
[TBL] [Abstract][Full Text] [Related]
18. Peritoneal dialysis for patients suffering from severe heart failure.
Sotirakopoulos NG; Kalogiannidou IM; Tersi ME; Mavromatidis KS
Clin Nephrol; 2011 Aug; 76(2):124-9. PubMed ID: 21762644
[TBL] [Abstract][Full Text] [Related]
19. Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study.
Konings CJ; Kooman JP; Schonck M; Gladziwa U; Wirtz J; van den Wall Bake AW; Gerlag PG; Hoorntje SJ; Wolters J; van der Sande FM; Leunissen KM
Kidney Int; 2003 Apr; 63(4):1556-63. PubMed ID: 12631373
[TBL] [Abstract][Full Text] [Related]
20. Predictors of a favourable response to icodextrin in peritoneal dialysis patients with ultrafiltration failure.
Wiggins KJ; Rumpsfeld M; Blizzard S; Johnson DW
Nephrology (Carlton); 2005 Feb; 10(1):33-6. PubMed ID: 15705179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
